Development of novel isatin-nicotinohydrazide hybrids with potent activity against susceptible/resistant Mycobacterium tuberculosis and bronchitis causing-bacteria.
J Enzyme Inhib Med Chem
; 36(1): 384-393, 2021 Dec.
Article
in En
| MEDLINE
| ID: mdl-33406941
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Bacterial Proteins
/
Drug Resistance, Bacterial
/
Alcohol Oxidoreductases
/
Hydrazines
/
Isatin
/
Anti-Bacterial Agents
/
Mycobacterium tuberculosis
Language:
En
Journal:
J Enzyme Inhib Med Chem
Journal subject:
BIOQUIMICA
/
QUIMICA
Year:
2021
Type:
Article
Affiliation country:
Egypt